EC Number | Application | Comment | Organism |
---|---|---|---|
6.3.2.10 | drug development | AbMurF is a target for the structure-based development of inhibitors to treat Acinetobacter baumannii infections | Acinetobacter baumannii |
EC Number | Cloned (Comment) | Organism |
---|---|---|
6.3.2.10 | gene murF, recombinant expression of His-tagged selenomethionine-substituted enzyme in Escherichia coli strain B834(DE3) | Acinetobacter baumannii |
EC Number | Crystallization (Comment) | Organism |
---|---|---|
6.3.2.10 | crystallization of two MurF-ATP complexes: the MurFATP complex and the MurF-ATP-UDP complex, trigonal crystals of Se-AbMurF with ATP are grown in a precipitant solution containing 20% w/v PEG 3000 and 0.1 M sodium citrate-citric acid, pH 5.5, crystals of the AbMurF-ATP-UDP complex are obtained by soaking experiments, trigonal crystals of the AbMurF-ATP complex isomorphous to those of the Se-AbMurF-ATP complex are grown in the mother liquor and are then transferred to a solution containing 20% glycerol, 20% PEG 3000, 0.1 M sodium citrate-citric acid, pH 5.5, and 15 mM UDP, 25 min soaking, monoclinic crystals of the AbMurF-ATP complex are grown in a precipitant solution containing 24% PEG 4000, 0.08 M Tris-HCl, pH 8.5, 0.16 M MgCl2, and 20% glycerol by the micro-batch crystallization method at 22°C, X-ray diffraction structure determination and analysis at 1.8-2.8 A resolution | Acinetobacter baumannii |
EC Number | Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|---|
6.3.2.10 | cytosol | - |
Acinetobacter baumannii | 5829 | - |
EC Number | Metals/Ions | Comment | Organism | Structure |
---|---|---|---|---|
6.3.2.10 | Mg2+ | required, the ATP-binding mode revealed by the crystal structure of the MurF-ATP complex confirms that a carbamoylated lysine and two Mg2+ ions are required for enzyme activity of MurF | Acinetobacter baumannii |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
6.3.2.10 | ATP + UDP-N-acetylmuramoyl-L-alanyl-gamma-D-glutamyl-L-lysine + D-alanyl-D-alanine | Acinetobacter baumannii | - |
ADP + phosphate + UDP-N-acetylmuramoyl-L-alanyl-gamma-D-glutamyl-L-lysyl-D-alanyl-D-alanine | - |
? | |
6.3.2.10 | ATP + UDP-N-acetylmuramoyl-L-alanyl-gamma-D-glutamyl-L-lysine + D-alanyl-D-alanine | Acinetobacter baumannii AB307-0294 | - |
ADP + phosphate + UDP-N-acetylmuramoyl-L-alanyl-gamma-D-glutamyl-L-lysyl-D-alanyl-D-alanine | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
6.3.2.10 | Acinetobacter baumannii | A0A0J9X1Z8 | - |
- |
6.3.2.10 | Acinetobacter baumannii AB307-0294 | A0A0J9X1Z8 | - |
- |
EC Number | Purification (Comment) | Organism |
---|---|---|
6.3.2.10 | recombinant His-tagged enzyme from Escherichia coli strain B834(DE3) by nickel affinity chromatography, gel filtration, and ultrafiltration | Acinetobacter baumannii |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
6.3.2.10 | ATP + UDP-N-acetylmuramoyl-L-alanyl-gamma-D-glutamyl-L-lysine + D-alanyl-D-alanine | - |
Acinetobacter baumannii | ADP + phosphate + UDP-N-acetylmuramoyl-L-alanyl-gamma-D-glutamyl-L-lysyl-D-alanyl-D-alanine | - |
? | |
6.3.2.10 | ATP + UDP-N-acetylmuramoyl-L-alanyl-gamma-D-glutamyl-L-lysine + D-alanyl-D-alanine | ATP and UDP binding mode analysis, overview | Acinetobacter baumannii | ADP + phosphate + UDP-N-acetylmuramoyl-L-alanyl-gamma-D-glutamyl-L-lysyl-D-alanyl-D-alanine | - |
? | |
6.3.2.10 | ATP + UDP-N-acetylmuramoyl-L-alanyl-gamma-D-glutamyl-L-lysine + D-alanyl-D-alanine | - |
Acinetobacter baumannii AB307-0294 | ADP + phosphate + UDP-N-acetylmuramoyl-L-alanyl-gamma-D-glutamyl-L-lysyl-D-alanyl-D-alanine | - |
? | |
6.3.2.10 | ATP + UDP-N-acetylmuramoyl-L-alanyl-gamma-D-glutamyl-L-lysine + D-alanyl-D-alanine | ATP and UDP binding mode analysis, overview | Acinetobacter baumannii AB307-0294 | ADP + phosphate + UDP-N-acetylmuramoyl-L-alanyl-gamma-D-glutamyl-L-lysyl-D-alanyl-D-alanine | - |
? | |
6.3.2.10 | additional information | the ATP-binding mode revealed by the crystal structure of the MurF-ATP complex confirms that a carbamoylated lysine and two Mg2+ ions are required for enzyme activity of MurF. UDP-MurF interactions are observed in the crystal structure of the MurF-ATP-UDP complex, depicting the characteristic substrate-binding mode of MurF. Structure-function analysis, overview | Acinetobacter baumannii | ? | - |
? | |
6.3.2.10 | additional information | the ATP-binding mode revealed by the crystal structure of the MurF-ATP complex confirms that a carbamoylated lysine and two Mg2+ ions are required for enzyme activity of MurF. UDP-MurF interactions are observed in the crystal structure of the MurF-ATP-UDP complex, depicting the characteristic substrate-binding mode of MurF. Structure-function analysis, overview | Acinetobacter baumannii AB307-0294 | ? | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
6.3.2.10 | AbMurF | - |
Acinetobacter baumannii |
6.3.2.10 | MurF | - |
Acinetobacter baumannii |
EC Number | Cofactor | Comment | Organism | Structure |
---|---|---|---|---|
6.3.2.10 | ATP | the ATP-binding mode revealed by the crystal structure of the MurF-ATP complex confirms that a carbamoylated lysine and two Mg2+ ions are required for enzyme activity of MurF | Acinetobacter baumannii |
EC Number | General Information | Comment | Organism |
---|---|---|---|
6.3.2.10 | physiological function | MurF adds D-Ala-D-Ala dipeptide to UDP-N-acetylmuramyl-L-Ala-c-D-Glu-m-DAP (or L-Lys) in an ATP-dependent manner, which is the last step in the biosynthesis of monomeric precursor of peptidoglycan for bacterial cell wall synthesis | Acinetobacter baumannii |